Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2021
Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levelsMarie-Anne Goyette, Islam E Elkholi, Chloé Apcher, et al.Nature Cell Biology|December 25, 2019
Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanismsHalil Bagci, Neera Sriskandarajah, Amélie Robert, et al.Nature Cell Biology|February 12, 2020
Author Correction: Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanismsHalil Bagci, Neera Sriskandarajah, Amélie Robert, et al.Biorxiv : the Preprint Server for Biology|August 30, 2024
Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.Cancer Research|May 15, 2025
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis InitiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.The EMBO Journal|November 1, 2025
Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumorsJacopo Boni, Míriam Fernández-González, HyeRim Han, et al.Scientific Reports|January 29, 2021
Investigating the causal role of MRE11A p.E506* in breast and ovarian cancerIslam E Elkholi, Massimo Di Iorio, Somayyeh Fahiminiya, et al.Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.Pageof 2